(PharmaNewsWire.Com, September 12, 2017 ) The Middle East and Africa Varicose Vein Treatment Market was worth USD 17.43 million in 2016 and estimated to be growing at a CAGR of 6.5%, to reach USD 23.8 million by 2021. The varicose vein treatment market is primarily driven by the rising incidence of varicose veins. This condition of enlarged, gnarled veins, appearing mostly in the feet and legs, is caused by several factors including pregnancy, hormonal changes, genetic disorders, obesity, sleep disorders, high blood pressure levels, and lifestyle-associated factors such as prolonged standing and increased stress levels.
The market is majorly driven by the bettering patient compliance owing to the advent of durable and safe techniques to address the huge burden of varicose vein incidences and the increased access to varicose vein medical devices. In addition, the healthcare industry has experienced a new trend of removing or destroying the surface veins with enhanced patient experience. However, dearth of trained vascular surgeons and high cost of varicose vein treatment procedures can hinder the growth of this market.
This report broadly segments the varicose vein treatment market into mode of treatment and products. On the basis of mode of treatment, the varicose vein treatment market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping. The endovenous ablation segment is expected to command the major share of the varicose vein treatment market, by mode of treatment. Based on type of products, the varicose vein treatment market is segmented into ablation devices, venous closure products, and surgical products. The radiofrequency ablation devices segment is expected to command the major share of the ablation devices market for varicose vein treatment. On the basis of geography, the market is analysed under various regions- Middle East and Africa.
The major players in the varicose vein treatment market are Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); biolitec AG (Austria); Syneron Medical Ltd. (Israel); Lumenis Ltd. (Israel); Dornier MedTech GmbH (Germany); Energist Group (U.K.); Eufoton s.r.l. (Italy); Vascular Solutions, Inc. (U.S.); Quanta System S.p.A. (Italy); Sciton, Inc. (U.S.); Fotona d.o.o. (Slovenia); BTG plc (U.K.); and Merz Aesthetics (U.S.)
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: